Imidazoles
Imidazoles are five-membered ring heterocycles containing two nitrogen atoms. These compounds play a crucial role in organic synthesis and medicinal chemistry, especially for their antifungal and antimicrobial properties. At CymitQuimica, we offer a diverse selection of high-quality imidazoles to support your research and industrial needs.
Subcategories of "Imidazoles"
Products of "Imidazoles"
1-[4-(2-chloro-4-fluorophenyl)-1H-imidazol-2-yl]methanamine
Ref: 10-F605646
250mg | Discontinued | Request information |
2-oxo-2,3-dihydro-1H-imidazole-4-carbaldehyde
Ref: 10-F775739
1g | Discontinued | Request information |
Ref: 10-F510081
1g | Discontinued | Request information |
methyl({[4-(4-methylphenyl)-1H-imidazol-2-yl]methyl})amine
Ref: 10-F688345
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
3-[1-(1,3-thiazol-4-ylmethyl)-1H-imidazol-2-yl]piperidine trihydrochloride
Ref: 10-F392517
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
10g | Discontinued | Request information |
1-[4-(4-chlorophenyl)-1H-imidazol-2-yl]methanamine dihydrochloride
Ref: 10-F616590
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information |
3-(4,5-Dimethyl-1h-imidazol-2-yl)piperidine
Ref: 10-F687096
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
1-ethyl-5-(4-methoxyphenyl)-2,3-dihydro-1H-imidazole-2-thione
Ref: 10-F710815
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
2-Chloro-6-(1h-imidazol-1-yl)benzaldehyde
Ref: 10-F651205
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
4-Nitro-1-phenyl-1H-imidazole
Ref: 10-F336470
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
10g | Discontinued | Request information | |
250mg | Discontinued | Request information |
1-(Dimethylcarbamoyl)-3-methyl-1h-imidazol-3-ium iodide
Ref: 10-F677435
1g | Discontinued | Request information | |
2.5g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
3-(1-Methyl-1h-imidazol-2-yl)azetidin-3-ol
Ref: 10-F746924
250mg | Discontinued | Request information |
1-Butyl-3-methyl-1H-imidazol-3-ium (S)-2-hydroxypropanoate
Ref: 10-F776734
1g | Discontinued | Request information | |
5g | Discontinued | Request information |
1,2-Dimethyl-4-phenyl-1h-imidazol-5-amine
Ref: 10-F688904
1g | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
1-((Tetrahydrofuran-3-yl)methyl)-1h-imidazol-2-amine
Ref: 10-F698548
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
N-(2-bromophenyl)-2-((1-methyl-1H-imidazol-2-yl)thio)acetamide
Ref: 10-F753373
1g | Discontinued | Request information |
5-(4-bromophenyl)-1-methyl-2,3-dihydro-1H-imidazole-2-thione
Ref: 10-F712329
1g | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
3-((1-Methyl-1h-imidazol-2-yl)oxy)benzoic acid hydrochloride
Ref: 10-F739712
1g | Discontinued | Request information |
1-((3-Methylcyclohexyl)methyl)-1h-imidazol-2-amine
Ref: 10-F698545
250mg | Discontinued | Request information |
n-(2-Morpholinoethyl)-1h-imidazole-1-carboxamide
Ref: 10-F706412
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |